2014 Annual Meeting | New Antithrombotic Agents for Stroke Prevention
| 01:00 PM - 01:10 PM |
Introduction
Antonio Culebras, MD, FAHA, FAAN |
|
| 01:00 PM - 05:00 PM | Abstract |
001 - Effect of Apixaban on All-Cause Mortality in Atrial Fibrillation: An Imputed Placebo Analysis
|
| 01:00 PM - 05:00 PM | Abstract |
001 - Oral Anticoagulant Therapy Is Associated with Cerebral Microbleeds
Saloua Akoudad |
| 01:00 PM - 05:00 PM | Abstract |
002 - Risk of Bleeding from Antithrombotic Agents (AT) in Patients with Cerebral Cavernous Malformations (CCMs).
Robert J. Wityk, MD |
| 01:00 PM - 05:00 PM | Abstract |
002 - Mobile Cardiac Outpatient Telemetry Identifies Occult Atrial Fibrillation After Cryptogenic Stroke
Erin E. Ingala, MD |
| 01:00 PM - 05:00 PM | Abstract |
003 - Diagnostic Yield of Prolonged Cardiac Rhythm Monitoring in Cryptogenic Stroke
Rizwan Kalani, MD |
| 01:00 PM - 05:00 PM | Abstract |
003 - Use of Apixaban and Warfarin in Patients Undergoing Procedures: Insights from ARISTOTLE
|
| 01:00 PM - 05:00 PM | Abstract |
004 - Stroke in very old patients
Drini Dobi, MD, PhD |
| 01:00 PM - 05:00 PM | Abstract |
005 - Cryptogenic Stroke with No Cause Demonstrates the Outcome Prediction Utility of TOAST Classifications in a Large Stroke Patient Sample
|
| 01:00 PM - 05:00 PM | Abstract |
005 - Direct Thrombin Inhibitors May Have A Decreased Risk Of Intracerebral Hemorrhage Compared With Older Anticoagulants
Adrienne Daebrich |
| 01:00 PM - 05:00 PM | Abstract |
006 - The incidence of secondary stroke prevention medication following hospitalization for ischemic stroke
Karen C. Albright, DO, MPH |
| 01:00 PM - 05:00 PM | Abstract |
007 - Neuroanatomical Correlates of Atrial Fibrillation: A Longitudinal MRI Study
|
| 01:00 PM - 05:00 PM | Abstract |
008 - Etiologies of Intracerebral Hemorrhages from 2009-2012 at Mayo Clinic-Rochester
James P. Klaas, MD, FAAN |
| 01:00 PM - 05:00 PM | Abstract |
009 - Warfarin associated intracerebral hemorrhage in Hong Kong Chinese
Kay Cheong Teo, MD |
| 01:00 PM - 05:00 PM | Abstract |
010 - Stroke patients and diagnostic testing- the weekend waiting game!
Sally V. Mathias, MD, FANA, FAES |
| 01:10 PM - 01:40 PM |
The "New" Oral Anticoagulants for Stroke Prevention
Cathy A. Sila, MD, FAAN |
|
| 01:40 PM - 02:10 PM |
Periprocedural Management of Antithrombotic Therapy in Patients with Ischemic Cerebrovascular Disease
Jose Biller, MD, FACP, FAHA, FAAN |
|
| 02:10 PM - 02:20 PM |
Break
|
|
| 02:20 PM - 02:50 PM |
Management of Bleeding Complications
Julius Latorre, MD, FAAN |
|
| 02:50 PM - 03:15 PM |
Potential Future Uses of Novel Oral Anticoagulants
Mitchell S. Elkind, MD, MS, FAAN |
|
| 03:15 PM - 03:30 PM |
Discussion
|
|
| 03:30 PM - 04:30 PM |
Poster Rounds
|
|
| 04:30 PM - 05:00 PM |
Data Blitz
|
| Seemant Chaturvedi, MD, FAHA, FAAN | Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS. |
| Antonio Culebras, MD, FAHA, FAAN | Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for MEDLINK NEUROLOGY. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Culebras has received publishing royalties from a publication relating to health care. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a RESEARCH REVIEWER with DEPARTMENT OF DEFENSE. Dr. Culebras has received personal compensation in the range of $500-$4,999 for serving as a REVIEWER with DOD. |
| Jose Biller, MD, FACP, FAHA, FAAN | Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care. |
| Cathy A. Sila, MD, FAAN | The institution of Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syntactx . Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca . |
| Julius Latorre, MD, FAAN | Dr. Latorre has nothing to disclose. |
| Mitchell S. Elkind, MD, MS, FAAN | Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. The institution of Dr. Elkind has received research support from BMS-Pfizer Alliance for Eliquis. The institution of Dr. Elkind has received research support from Roche. Dr. Elkind has received publishing royalties from a publication relating to health care. Dr. Elkind has a non-compensated relationship as a Officer with American Heart Association that is relevant to AAN interests or activities. |
| Sheryl Martin-Schild, MD, PhD, FAAN | No disclosure on file |
| Hamza I. Maqsood, MD | Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Sherri A. Braksick, MD, FAAN | Dr. Braksick has nothing to disclose. |
| Dominique Monlezun, Jr | No disclosure on file |
| No disclosure on file | |
| Ramy El Khoury, MD, FAAN | No disclosure on file |
| Robert D. Brown, Jr., MD, MPH, FAAN | Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care. |
| Mushtaq H. Qureshi, MD | No disclosure on file |
| Jennifer Osborne, NP | No disclosure on file |
| Alexander George | No disclosure on file |
| Michael G. Hanna, MD, MBBS | No disclosure on file |
| Matthew L. Flaherty, MD | Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care. |
| Ahn Hee Seung | No disclosure on file |
| James E. Siegler III, MD | Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai. |
| Jennifer E. Fugate, DO | No disclosure on file |
| Raymond Hupperts | No disclosure on file |
| Kevin N. Sheth, MD, FAAN | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| Alejandro A. Rabinstein, MD, FAAN | Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainomix. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Rabinstein has received research support from Chiesi. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. |
| Adrienne Daebrich | No disclosure on file |
| Karen C. Albright, DO, MPH | Dr. Albright has nothing to disclose. |
| Daniel Woo, MD, FAAN | Dr. Woo has nothing to disclose. |
| James P. Klaas, MD, FAAN | No disclosure on file |
| Wi-Sun Ryu | No disclosure on file |
| Steven R. Messe, MD, FAHA, FAAN | Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group. |
| Shyam Prabhakaran, MD | Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care. |
| Brett L. Cucchiara, MD | Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elseiver. Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bayer. Dr. Cucchiara has received publishing royalties from a publication relating to health care. |
| Scott E. Kasner, MD, FAAN | Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diamedica. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from Bristol-Myers Squibb. The institution of Dr. Kasner has received research support from Medtronic. The institution of Dr. Kasner has received research support from WL Gore. |
| Michael T. Mullen, MD | Dr. Mullen has received publishing royalties from a publication relating to health care. |
| Robert G. Hart, MD | No disclosure on file |
| Richard A. Bernstein, MD | No disclosure on file |
| Jessica D. Lee, MD, FAAN | Dr. Lee has received personal compensation for serving as an employee of American Academy of Neurology. |
| Sally V. Mathias, MD, FANA, FAES | Dr. Mathias has nothing to disclose. |
| Ilana M. Ruff, MD | Dr. Ruff has nothing to disclose. |
| Yvonne M. Curran, MD | Dr. Curran has nothing to disclose. |
| Erin E. Ingala, MD | No disclosure on file |
| Rizwan Kalani, MD | No disclosure on file |
| Peter J. Koudstaal, MD | No disclosure on file |
| Robert J. Wityk, MD | No disclosure on file |
| Drini Dobi, MD, PhD | No disclosure on file |
| Jordan S. Dubow, MD | Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals. |
| Saloua Akoudad | No disclosure on file |
| Mira Kapisyzi, DO | No disclosure on file |
| Gary K. Lau, MBBS | Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care. |
| Shu Leong Ho, MD, FAAN | No disclosure on file |
| Mohammad Ikram | The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc. |
| Jera Kruja, MD | No disclosure on file |
| Kay Cheong Teo, MD | No disclosure on file |
| Sirwan Darweesh | No disclosure on file |
| Albert Hofman, MD, PhD | No disclosure on file |
| Raymond T. Cheung, MD, FAAN | No disclosure on file |
| Ryo Yamasaki | No disclosure on file |
| Timothy Cunniff, PharmD | Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences. |
| Luisa H. Klotz, MD | Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck. |
| Stephen Wanaski, PhD | Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences. |
| James M. Meyer, PharmD | No disclosure on file |
| Feride H. Frech, PhD | Dr. Frech has received personal compensation for serving as an employee of Eisai Inc. |